Nanomedicine for targeting cancer-associated fibroblasts in cancer therapy

Area of Science:

• Oncology
• Nanomedicine
• Biomaterials

Background:

• Cancer-associated fibroblasts (CAFs) are key players in tumor progression, angiogenesis, immune evasion, and treatment resistance.
• Targeting CAFs is crucial for developing effective cancer therapies.
• Nanomedicine provides tools for precise targeting and controlled drug delivery within the tumor microenvironment.

Purpose of the Study:

• To review emerging nanotechnologies for targeting cancer-associated fibroblasts (CAFs).
• To discuss therapeutic strategies utilizing functional nanomaterials for CAF targeting.
• To highlight challenges and future directions in CAF-targeted nanomedicine.

Main Methods:

• Review of recent literature on nanomedicine approaches for CAF targeting.
• Categorization of nanomaterials used: polymers, inorganic nanoparticles, cell membrane-based NPs, and protein-based NPs.
• Analysis of therapeutic strategies: direct CAF depletion, signaling pathway modulation, and CAF reprogramming.

Main Results:

• Functional nanomaterials show promise for precise CAF targeting, controlled drug release, and enhanced drug penetration.
• Various nanomedicine platforms are being developed to target CAFs.
• Therapeutic approaches include direct CAF elimination, pathway inhibition, and CAF reprogramming.

Conclusions:

• Nanomedicine offers promising avenues for developing clinically applicable CAF-targeted therapies.
• Future research should focus on versatile nanosystems and personalized treatment strategies.
• Overcoming challenges in advanced functional nanomaterials is key for clinical translation.